Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 7.79T | 7.25T | 9.19T | 8.51T | 6.33T |
Gross Profit | 1.15T | 1.07T | 1.05T | 895.33B | 675.42B |
EBITDA | 616.02B | 453.99B | 578.30B | 457.11B | 307.84B |
Net Income | 502.96B | 471.41B | 543.00B | 424.32B | 223.26B |
Balance Sheet | |||||
Total Assets | 9.20T | 8.92T | 7.95T | 8.26T | 6.94T |
Cash, Cash Equivalents and Short-Term Investments | 569.53B | 506.27B | 610.31B | 1.37T | 1.09T |
Total Debt | 2.54T | 2.68T | 2.09T | 2.44T | 2.43T |
Total Liabilities | 5.43T | 5.36T | 4.97T | 5.92T | 5.03T |
Stockholders Equity | 3.63T | 3.46T | 2.88T | 2.24T | 1.82T |
Cash Flow | |||||
Free Cash Flow | 420.39B | 289.10B | 502.07B | 210.11B | 272.98B |
Operating Cash Flow | 597.95B | 442.47B | 606.33B | 311.92B | 397.07B |
Investing Cash Flow | -367.03B | -334.43B | 156.81B | -79.66B | -116.26B |
Financing Cash Flow | -150.31B | -254.17B | -766.59B | -419.64B | -68.50B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
82 Outperform | $3.42T | 9.48 | 14.04% | 3.41% | 1.18% | 9.37% | |
80 Outperform | ¥11.12T | 12.08 | 10.17% | 3.49% | -4.85% | 2.78% | |
79 Outperform | ¥4.45T | 7.99 | 12.19% | 3.53% | 5.52% | 46.81% | |
78 Outperform | ¥4.90T | 9.69 | 13.98% | 3.42% | 7.44% | 8.25% | |
77 Outperform | $10.83T | 12.23 | 15.55% | 2.64% | 4.95% | 11.33% | |
76 Outperform | ¥8.52T | 9.73 | 11.74% | 3.35% | 10.04% | -13.06% | |
56 Neutral | HK$4.04B | -0.60 | 10.69% | 5.34% | -6.34% | -55.88% |